Google said that it was banning ads for unproven medical treatments. Google policy adviser Adrienne Biddings noted in a blog post, “This new policy will prohibit ads selling treatments that have no established biomedical or scientific basis.”
Biddings said Google would “prohibit advertising for unproven or experimental medical techniques such as most stem cell therapy, cellular (non-stem) therapy and gene therapy.“
Reports say that Google will also ban, “treatments that are rooted in basic scientific findings and preliminary clinical experience, but currently, have insufficient formal clinical testing to justify widespread clinical use.“
Further, in a report “the online giant said that it decided due to a rise in bad actors attempting to take advantages of individuals by offering untested, deceptive treatments.”
The company said this was not an effort to diminish the importance of medical discoveries but maintained that “monitored, regulated clinical trials are the most reliable way to test and prove important medical advances.“
Google decided after consulting the experts in the field, and the move was promoted by the president of the International Society for Stem Cell Research, Deepak Srivastava.
Srivastava said, “The premature marketing and commercialization of unproven stem cell products threatens public health, their confidence in biomedical research, and undermines the development of legitimate new therapies.“
Research says that earlier this year, Facebook and Google-owned Youtube took necessary steps to reduce the spread of misleading health care claims. This was done after the media revealed bogus cancer-curing ways on social media.
Facebook said it made changes as part of efforts to reduce the spread of misleading medical claims, including from groups opposing the use of recommended vaccines.
Based on interviews with doctors, lawyers, privacy experts, and others, a Wall Street Journal Report, found numerous false or misleading claims about cancer therapies online.
These included videos advocating the use of potentially dangerous cell-killing ointments, unverified dietary regimes, or unapproved screening techniques.
Angelique Chrisafis is the Guardian’s Paris correspondent. She is responsible for churning out quality articles based on her research while keeping an eye on the tech world. She likes technology, gadgets, and food. Works as an individual contributor to the team.